Gamunex Innrennslislyf, lausn 100 mg/ml Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

gamunex innrennslislyf, lausn 100 mg/ml

grifols deutschland gmbh* - human normal immunoglobulin (iv) - innrennslislyf, lausn - 100 mg/ml

Enspryng Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

enspryng

roche registration gmbh - satralizumab - neuromyelitis optica - Ónæmisbælandi lyf - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.

Gemcitabine WH Innrennslisstofn, lausn 1000 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

gemcitabine wh innrennslisstofn, lausn 1000 mg

williams & halls ehf.* - gemcitabinum hýdróklóríð - innrennslisstofn, lausn - 1000 mg

Stalevo (Lyfjaver) Filmuhúðuð tafla 100 mg/25 mg/200 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

stalevo (lyfjaver) filmuhúðuð tafla 100 mg/25 mg/200 mg

lyfjaver ehf. - entacaponum inn; levodopum inn; carbidopum inn - filmuhúðuð tafla - 100 mg/25 mg/200 mg